Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Beaulieu

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
Archives of Physical Medicine and Rehabilitation|July 28, 2015
Predictors of Agitated Behavior During Inpatient Rehabilitation for Traumatic Brain InjuryJennifer Bogner, Ryan S Barrett, Flora M Hammond, et al.
Journal of Medicinal Chemistry|August 2, 2012
Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV)Pierre L Beaulieu, Michael Bös, Michael G Cordingley, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2013
Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: discovery of a quinazolinone chemotypePierre L Beaulieu, René Coulombe, Jianmin Duan, et al.
Journal of Medicinal Chemistry|March 29, 2000
2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitorsP L Beaulieu, P C Anderson, D R Cameron, et al.
Organic Letters|August 28, 2004
Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humansAnne-Marie Faucher, Murray D Bailey, Pierre L Beaulieu, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2006
Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffoldsPierre L Beaulieu, James Gillard, Darren Bykowski, et al.
Journal of Inherited Metabolic Disease|March 22, 2018
A family segregating lethal neonatal coenzyme Q<sub>10</sub> deficiency caused by mutations in COQ9Amanda C Smith, Yoko Ito, Afsana Ahmed, et al.
JIMD Reports|June 17, 2016
Severe Neonatal Presentation of Mitochondrial Citrate Carrier (SLC25A1) DeficiencyAmanda Smith, Skye McBride, Julien L Marcadier, et al.
Orphanet Journal of Rare Diseases|November 28, 2012
Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiencyHugh J McMillan, Thea Worthylake, Jeremy Schwartzentruber, et al.
Orphanet Journal of Rare Diseases|April 30, 2013
Intellectual disability associated with a homozygous missense mutation in THOC6Chandree L Beaulieu, Lijia Huang, A Micheil Innes, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Archives of Physical Medicine and Rehabilitation|July 28, 2015
Predictors of Agitated Behavior During Inpatient Rehabilitation for Traumatic Brain InjuryJennifer Bogner, Ryan S Barrett, Flora M Hammond, et al.
Journal of Medicinal Chemistry|August 2, 2012
Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV)Pierre L Beaulieu, Michael Bös, Michael G Cordingley, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2013
Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: discovery of a quinazolinone chemotypePierre L Beaulieu, René Coulombe, Jianmin Duan, et al.
Journal of Medicinal Chemistry|March 29, 2000
2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitorsP L Beaulieu, P C Anderson, D R Cameron, et al.
Organic Letters|August 28, 2004
Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humansAnne-Marie Faucher, Murray D Bailey, Pierre L Beaulieu, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2006
Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffoldsPierre L Beaulieu, James Gillard, Darren Bykowski, et al.
Journal of Inherited Metabolic Disease|March 22, 2018
A family segregating lethal neonatal coenzyme Q<sub>10</sub> deficiency caused by mutations in COQ9Amanda C Smith, Yoko Ito, Afsana Ahmed, et al.
JIMD Reports|June 17, 2016
Severe Neonatal Presentation of Mitochondrial Citrate Carrier (SLC25A1) DeficiencyAmanda Smith, Skye McBride, Julien L Marcadier, et al.
Orphanet Journal of Rare Diseases|November 28, 2012
Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiencyHugh J McMillan, Thea Worthylake, Jeremy Schwartzentruber, et al.
Orphanet Journal of Rare Diseases|April 30, 2013
Intellectual disability associated with a homozygous missense mutation in THOC6Chandree L Beaulieu, Lijia Huang, A Micheil Innes, et al.
Pageof 19